NASDAQ · Biotechnology

KRYS (KRYS) Stock

$312.57 -8.37% NASDAQ: KRYS Healthcare

Valuation

MetricValue
Price$312.57
Market Cap$9.21B
P/E Ratio42.90
P/B Ratio7.09
P/S Ratio20.72
EPS (TTM)$6.84
52-Week High$381.30
52-Week Low$130.50
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE16.80%
ROA15.37%
ROCE13.20%
Gross Margin41.39%
Operating Margin41.39%
Net Margin53.92%
Debt/Equity0.01
Current Ratio9.95

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$51.0M$291.0M$389.0M
Operating Profit$-68.0M$-145.0M$-110.0M$66.0M$161.0M
Net Profit$-70.0M$-140.0M$11.0M$89.0M$205.0M
EPS$-3.13$-5.49$0.39$3.00$6.84
Op Margin——-216.4%22.6%41.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$626.0M$558.0M$818.0M$1.1B$1.3B
Total Liabilities$33.0M$36.0M$40.0M$109.0M$114.0M
Cash$341.0M$162.0M$358.0M$345.0M$496.0M
Borrowings$8.0M$9.0M$8.0M$7.0M$9.0M

Latest News

These Are 5 Of The Best Stocks To Buy Or Watch Now Investor's Business Daily · Jul 10, 2026 3 Soaring Stocks That May Have More Upside Ahead Motley Fool · Jul 7, 2026 Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock? Zacks · Jun 29, 2026 Entertainment Stocks Madison Square Garden, Sphere Rally To New Highs Investor's Business Daily · Jun 26, 2026 The Brown Capital Management Small Company Fund Bets on Krystal Biotech (KRYS) for Its Resilient Revenue Stream Insider Monkey · Jun 24, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-48.0M$-101.0M$-89.0M$123.0M$201.0M
Investing Cash Flow$-295.0M$-167.0M$71.0M$-168.0M$-70.0M
Financing Cash Flow$-8.0M$-1.0M$-1.0M$-5.0M$-14.0M
Net Cash Flow$73.0M$-179.0M$196.0M$-13.0M$151.0M
Free Cash Flow$-116.0M$-154.0M$-101.0M$119.0M$189.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA48.60
FCF Yield2.75%
Quick Ratio9.06
Interest Coverage—
Return 1Y128.96%
Return 3Y181.82%
Return 5Y444.50%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ACLXArcellx, Inc. $115.07 +0.02% -28.27 $6.73B 0.00%
ALKS $50.71 -3.84% 25.87 $8.45B 0.00%
ARWR $86.01 +1.61% -7397.00 $12.12B 0.00%
CRSP $46.73 +0.41% -12.98 $4.51B 0.00%
MTSRMetsera, Inc. $70.50 -0.35% -28.09 $7.43B 0.00%

About KRYS

KRYS is led by CEO Krish S. Krishnan, employs 295 people, headquartered in Pittsburgh, US, publicly traded since 2017.

KRYS stock trades at $312.57 with a market capitalization of $9.21B. The stock is valued at a price-to-earnings (P/E) ratio of 42.90, price-to-book of 7.09, price-to-sales of 20.72. Over the past 52 weeks the stock has ranged between $130.50 and $381.30, and currently trades 18.0% below its 52-week high.

On profitability, KRYS generates a return on equity (ROE) of 16.80%, above the typical market average, return on capital employed of 13.20%, an operating margin of 41.39%, a net profit margin of 53.92%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides